1. 551. MK-8591 Does Not Alter the Pharmacokinetics of the Oral Contraceptives Ethinyl Estradiol and Levonorgestrel. (26th November 2018) Authors: Ankrom, Wendy; Jonathan, Daniel; Rudd, Deanne; Zhang, Sandra; Fillgrove, Kerry; Gravesande, Kezia; Matthews, Randolph; Brimhall, Darin; Stoch, Aubrey; Iwamoto, Marian Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase 1, open‐label study to evaluate the drug interaction between islatravir (MK‐8591) and the oral contraceptive levonorgestrel/ethinyl estradiol in healthy adult females. Issue 12 (22nd December 2021) Authors: Ankrom, Wendy; Jackson Rudd, Deanne; Zhang, Saijuan; Fillgrove, Kerry L.; Gravesande, Kezia N.; Matthews, Randolph P.; Brimhall, Darin; Stoch, S. Aubrey; Iwamoto, Marian N. Journal: Journal of the International AIDS Society Issue: Volume 24:Issue 12(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Atogepant Has No Clinically Relevant Effects on the Pharmacokinetics of an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Participants. (16th April 2020) Authors: Ankrom, Wendy; Xu, Jialin; Vallee, Marie‐Helene; Dockendorf, Marissa F.; Armas, Danielle; Boinpally, Ramesh; Min, K. Chris Journal: Journal of clinical pharmacology Issue: Volume 60:Number 9(2020) Page Start: 1157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effects of CYP3A4 and P-glycoprotein inhibition or induction on the pharmacokinetics of ubrogepant in healthy adults: Two phase 1, open-label, fixed-sequence, single-center, crossover trials. (5th August 2021) Authors: Jakate, Abhijeet; Boinpally, Ramesh; Butler, Matthew; Ankrom, Wendy; Dockendorf, Marissa F; Periclou, Antonia Journal: Cephalalgia reports Issue: Volume 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target. Issue 1 (15th January 2016) Authors: Ankrom, Wendy; Wood, Harold B.; Xu, Jiayi; Geissler, Wayne; Bateman, Tom; Chatterjee, Manash S.; Feng, Kung‐I; Metzger, Joseph M.; Strapps, Walter R.; Tadin‐Strapps, Marija; Seiffert, Dietmar; Andre, Patrick Journal: Pharmacology research & perspectives Issue: Volume 4:Issue 1(2016:Feb.) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Safety, tolerability, and pharmacokinetics of single‐ and multiple‐dose administration of islatravir (MK‐8591) in adults without HIV. Issue 5 (31st August 2021) Authors: Matthews, Randolph P.; Ankrom, Wendy; Friedman, Evan; Jackson Rudd, Deanne; Liu, Yang; Mogg, Robin; Panebianco, Deborah; De Lepeleire, Inge; Petkova, Magdalena; Grobler, Jay A.; Stoch, Selwyn Aubrey; Iwamoto, Marian Journal: Clinical and translational science Issue: Volume 14:Issue 5(2021) Page Start: 1935 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Single Oral Doses of MK-8507, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor, Suppress HIV-1 RNA for a Week. (15th October 2021) Authors: Schürmann, Dirk; Jackson Rudd, Deanne; Schaeffer, Andrea; De Lepeleire, Inge; Friedman, Evan J.; Robberechts, Martine; Zhang, Saijuan; Liu, Yang; Kandala, Bhargava; Keicher, Christian; Däumer, Martin; Hofmann, Jörg; Grobler, Jay A.; Stoch, S. Aubrey; Iwamoto, Marian; Ankrom, Wendy Journal: Journal of acquired immune deficiency syndromes Issue: Volume 89:Number 2(2022) Page Start: 191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Single Oral Doses of MK-8507, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor, Suppress HIV-1 RNA for a Week. (1st February 2022) Authors: Schürmann, Dirk; Jackson Rudd, Deanne; Schaeffer, Andrea; De Lepeleire, Inge; Friedman, Evan J.; Robberechts, Martine; Zhang, Saijuan; Liu, Yang; Kandala, Bhargava; Keicher, Christian; Däumer, Martin; Hofmann, Jörg; Grobler, Jay A.; Stoch, S. Aubrey; Iwamoto, Marian; Ankrom, Wendy Journal: Journal of acquired immune deficiency syndromes Issue: Volume 89:Number 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The effect of multiple doses of ubrogepant on the pharmacokinetics of an oral contraceptive in healthy women: Results of an open-label, single-center, two-period, fixed-sequence study. (21st February 2020) Authors: Li, Chi-Chung; Palcza, John; Xu, Jialin; Thornton, Bob; Ankrom, Wendy; Jakate, Abhijeet; Marcantonio, Eugene E Journal: Cephalalgia reports Issue: Volume 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Ubrogepant Is Not Associated With Clinically Meaningful Elevations of Alanine Aminotransferase in Healthy Adult Males. Issue 3 (3rd January 2020) Authors: Ankrom, Wendy; Bondiskey, Phung; Li, Chi‐Chung; Palcza, John; Liu, Wen; Dockendorf, Marissa F.; Matthews, Catherine; Panebianco, Deborah; Reynders, Tom; Wagner, John A.; Jakate, Abhijeet; Mesens, Sofie; Kraft, Walter K.; Marcantonio, Eugene E. Journal: Clinical and translational science Issue: Volume 13:Issue 3(2020) Page Start: 462 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗